Biography of Angelika Jahreis
Last update: November 29, 2023Career
Angelika was Senior Vice President and Global Head Immunology and Clinical Development Excellence at Novartis, and Vice President, Rheumatology and Autoimmunity at Gilead Sciences. Angelika Jahreis joined AgomAb Therapeutics in 2023.
Angelika Jahreis is currently Director at AgomAb Therapeutics - View - AgomAb Therapeutics org chart
Create your alert
to follow the career of Angelika Jahreis.
Education
Angelika Jahreis has a PhD in Medicine & Immunology from University of Freiburg.
They have also studied at University of Freiburg :
Find more alumni from University of Freiburg
More about Angelika Jahreis
Selected links
Do you need to know more about Angelika Jahreis? More results.
Participate
Social media
- Angelika Jahreis on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Angelika Jahreis
The colleagues of Angelika Jahreis
Company Colleagues
- At AgomAb Therapeutics, Angelika Jahreis has 14 colleagues including Tim Knotnerus (CEO & Director), John Haurum (Chairman of the Board)…
Industry Colleagues
- In the Biotechnology industry, Angelika Jahreis has 30,324 colleagues in 2,286 companies located in 40 countries. 14,359 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Angelika Jahreis.
